BHC — BAUSCH HEALTH COMPANIES INC.

Public company

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BHC?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong accumulation · 4 buying vs 0 selling last quarter
75
Macro Tailwind
Macro conditions are a headwind for this sector
38
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their BHC position last quarter, 4 bought and 0 sold (100% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).

Supporting evidence
  • +4 tracked investors added or increased positions last quarter (Izzy Englander, Steve Cohen, Ken Griffin, …)
  • +4 tracked investors reported holding BHC at their latest filing
Contradicting evidence — always shown
  • −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.

About BAUSCH HEALTH COMPANIES INC. (BHC)

BAUSCH HEALTH COMPANIES INC. (BHC) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Carl Icahn (Icahn Capital), valued at $368M. Across recent filings, tracked investors recorded 9 new positions, 3 increased, 6 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BHC

52
/100
Mixed Activity
Added / Increased12
Reduced6
Exited5
BearishBullish
Crowded Trade Score™

How many top investors track BHC

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

BHC Ownership Composition

How BAUSCH HEALTH COMPANIES INC. is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
89% of tracked value
Institutions
4
tracked investors
Total Reported
$50.3M
combined 13F value
Types2
  • Multi-Strategy / Quant89.1%
  • Macro10.9%
Multi-Strategy / Quant(3)
89.1%
Macro(1)
10.9%

Tracked investors currently reporting BHC

2 tracked investors have since exited this position — listed separately below.

  • Ken GriffinSep 30, 2026
    Citadel Advisors
    Shares
    3.1M
    Value
    $17.8M
    % Portfolio
    0.00%
  • Izzy EnglanderSep 30, 2026
    Millennium Management
    Shares
    1.3M
    Value
    $7.6M
    % Portfolio
    0.00%
  • Steve CohenSep 30, 2026
    Point72 Asset Management
    Shares
    3.3M
    Value
    $19.3M
    % Portfolio
    0.02%
  • Ray DalioSep 30, 2026
    Bridgewater Associates
    Shares
    942.6K
    Value
    $5.5M
    % Portfolio
    0.02%

Previously held BHC

These investors reported BHC in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Carl IcahnIcahn Capital34.7M$231.2MJun 30, 2025
Howard MarksOaktree Capital Management1.3M$10.2MDec 31, 2024

Recent activity

Frequently asked questions

How many institutional investors hold BHC?
4 tracked institutional investors disclosed a position in BHC (BAUSCH HEALTH COMPANIES INC.) in their most recent 13F filing.
Who is the largest institutional holder of BHC?
Carl Icahn, Icahn Capital, holds the largest disclosed position in BHC, valued at $368M.
Did institutional ownership of BHC increase or decrease?
Across recent 13F filings, tracked investors recorded 9 new positions, 3 increased, 6 reduced, and 5 fully exited BHC.
Where does this BHC ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
BHC (BAUSCH HEALTH COMPANIES INC.) — Institutional Holders — InvestorLens